Couchbase (BASE) Financials

$24.49 +5.56 (+29.37%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$24.57 +0.08 (+0.34%)

As of 06/20/2025 07:56 PM Eastern

Annual Income Statements for Couchbase

This table shows Couchbase's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-29	-44	-61	-68	-80	-75
Consolidated Net Income / (Loss)	-29	-40	-58	-68	-80	-75
Net Income / (Loss) Continuing Operations	-29	-40	-58	-68	-80	-75
Total Pre-Tax Income	-28	-39	-57	-67	-79	-73
Total Operating Income	-30	-33	-56	-69	-85	-79
Total Gross Profit	75	92	109	135	158	185
Total Revenue	83	103	124	155	180	209
Operating Revenue	83	103	124	155	180	209
Total Cost of Revenue	7.80	12	15	20	22	25
Operating Cost of Revenue	7.80	12	15	20	22	25
Total Operating Expenses	105	125	165	204	242	263
Selling, General & Admin Expense	16	16	24	33	43	51
Marketing Expense	58	70	89	111	131	142
Research & Development Expense	32	39	52	58	64	71
Impairment Charge	-	-	0.00	0.00	5.16	0.00
Restructuring Charge	-	0.00	0.00	1.66	0.05	0.00
Total Other Income / (Expense), net	1.85	-5.86	-0.96	1.86	5.71	5.80
Interest Expense	4.66	6.97	0.66	0.10	0.04	0.06
Other Income / (Expense), net	6.51	1.11	-0.30	1.96	5.75	5.86
Income Tax Expense	0.77	1.04	1.02	1.04	1.36	1.80
Basic Earnings per Share	($5.33)	($7.71)	($2.37)	($1.53)	($1.70)	($1.45)
Weighted Average Basic Shares Outstanding	5.49M	5.72M	25.78M	44.79M	47.18M	51.31M
Diluted Earnings per Share	($5.33)	($7.71)	($2.37)	($1.53)	($1.70)	($1.45)
Weighted Average Diluted Shares Outstanding	5.49M	5.72M	25.78M	44.79M	47.18M	51.31M
Weighted Average Basic & Diluted Shares Outstanding	-	-	44.17M	45.61M	49.26M	53.10M
Cash Dividends to Common per Share	-	$0.00	$0.00	$0.00	$0.00	$0.00

This table shows Couchbase's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	10/31/2022	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025
Net Income / (Loss) Attributable to Common Shareholders	-17	-17	-22	-21	-16	-21	-21	-20	-18	-16	-18
Consolidated Net Income / (Loss)	-17	-17	-22	-21	-16	-21	-21	-20	-18	-16	-18
Net Income / (Loss) Continuing Operations	-17	-17	-22	-21	-16	-21	-21	-20	-18	-16	-18
Total Pre-Tax Income	-16	-17	-21	-21	-16	-21	-21	-19	-17	-15	-17
Total Operating Income	-17	-19	-23	-22	-18	-23	-23	-21	-19	-16	-19
Total Gross Profit	34	36	35	37	41	45	46	45	45	49	50
Total Revenue	39	42	41	43	46	50	51	52	52	55	57
Operating Revenue	39	42	41	43	46	50	51	52	52	55	57
Total Cost of Revenue	4.88	5.95	5.92	5.91	5.11	5.14	5.68	6.46	6.56	6.26	6.86
Operating Cost of Revenue	4.88	5.95	5.92	5.91	5.11	5.14	5.68	6.46	6.56	6.26	6.86
Total Operating Expenses	50	54	58	59	58	68	68	66	64	64	69
Selling, General & Admin Expense	8.83	8.21	9.63	10	11	12	13	13	13	13	11
Marketing Expense	27	29	33	32	32	34	38	36	34	34	38
Research & Development Expense	14	15	15	16	16	16	18	17	17	18	19
Total Other Income / (Expense), net	0.29	1.91	1.41	1.24	1.30	1.77	1.53	1.71	1.77	0.79	2.04
Interest Expense	0.03	0.03	0.03	0.02	0.00	-	0.00	0.03	0.02	0.01	0.02
Other Income / (Expense), net	0.32	1.94	1.43	1.26	1.30	1.77	1.53	1.74	1.79	0.80	2.05
Income Tax Expense	0.38	0.03	0.75	0.00	0.00	0.61	0.00	0.56	0.69	0.55	0.87
Basic Earnings per Share	($0.37)	($0.37)	($0.48)	($0.44)	($0.34)	($0.44)	($0.42)	($0.39)	($0.35)	($0.29)	($0.33)
Weighted Average Basic Shares Outstanding	44.93M	44.79M	45.84M	46.71M	47.59M	47.18M	49.79M	50.82M	51.83M	51.31M	53.65M
Diluted Earnings per Share	($0.37)	($0.37)	($0.48)	($0.44)	($0.34)	($0.44)	($0.42)	($0.39)	($0.35)	($0.29)	($0.33)
Weighted Average Diluted Shares Outstanding	44.93M	44.79M	45.84M	46.71M	47.59M	47.18M	49.79M	50.82M	51.83M	51.31M	53.65M
Weighted Average Basic & Diluted Shares Outstanding	45.17M	45.61M	46.41M	47.07M	48.07M	49.26M	50.31M	51.32M	52.35M	53.10M	54.08M
Cash Dividends to Common per Share	-	-	$0.00	-	-	-	$0.00	-	-	-	$0.00

This table details how cash moves in and out of Couchbase's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025
Net Change in Cash & Equivalents	9.18	19	58	-55	0.91	-11
Net Cash From Operating Activities	-22	-39	-42	-41	-27	-16
Net Cash From Continuing Operating Activities	-22	-39	-42	-41	-27	-16
Net Income / (Loss) Continuing Operations	-29	-40	-58	-68	-80	-75
Consolidated Net Income / (Loss)	-29	-40	-58	-68	-80	-75
Depreciation Expense	0.71	2.01	2.82	3.17	2.42	2.28
Amortization Expense	7.99	11	14	17	15	15
Non-Cash Adjustments To Reconcile Net Income	3.73	4.87	11	29	55	66
Changes in Operating Assets and Liabilities, net	-4.93	-17	-11	-22	-19	-24
Net Cash From Investing Activities	-4.71	-22	-92	-23	15	-4.85
Net Cash From Continuing Investing Activities	-4.71	-22	-92	-23	15	-4.85
Purchase of Property, Plant & Equipment	-4.71	-2.82	-0.82	-5.65	-4.71	-3.02
Purchase of Investments	0.00	-20	-112	-145	-131	-101
Sale and/or Maturity of Investments	0.00	0.90	21	127	151	99
Net Cash From Financing Activities	36	81	192	9.71	13	9.94
Net Cash From Continuing Financing Activities	36	81	192	9.71	13	9.94
Issuance of Common Equity	0.00	0.00	215	4.48	2.00	3.52
Other Financing Activities, net	0.98	2.19	7.49	5.22	11	6.42
Effect of Exchange Rate Changes	-0.14	0.16	-0.42	-0.40	-0.56	-0.62
Cash Interest Paid	3.85	5.95	0.62	0.10	0.04	0.05
Cash Income Taxes Paid	0.51	0.87	0.80	0.78	2.47	1.77

This table details how cash moves in and out of Couchbase's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	10/31/2022	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025
Net Change in Cash & Equivalents	-7.56	1.67	5.79	-4.80	5.47	-5.56	10	11	-30	-2.50	-2.49
Net Cash From Operating Activities	-15	-10	-7.18	-0.52	-13	-6.45	1.56	-4.85	-17	4.36	-6.78
Net Cash From Continuing Operating Activities	-15	-10	-7.18	-0.52	-13	-6.45	1.56	-4.85	-17	4.36	-6.78
Net Income / (Loss) Continuing Operations	-17	-17	-22	-21	-16	-21	-21	-20	-18	-16	-18
Consolidated Net Income / (Loss)	-17	-17	-22	-21	-16	-21	-21	-20	-18	-16	-18
Depreciation Expense	0.84	0.87	0.89	0.75	0.40	0.39	0.40	0.36	0.76	0.76	0.85
Amortization Expense	4.14	3.97	4.54	4.70	4.50	1.19	3.20	4.18	4.38	2.33	4.79
Non-Cash Adjustments To Reconcile Net Income	7.64	6.73	9.22	12	12	21	16	16	16	19	14
Changes in Operating Assets and Liabilities, net	-11	-5.15	0.05	2.57	-14	-8.01	3.21	-5.84	-20	-1.96	-8.25
Net Cash From Investing Activities	5.56	10	10	-6.87	15	-2.67	3.70	15	-15	-7.74	1.38
Net Cash From Continuing Investing Activities	5.56	10	10	-6.87	15	-2.67	3.70	15	-15	-7.74	1.38
Purchase of Property, Plant & Equipment	-1.62	-1.55	-1.29	-1.07	-1.07	-1.29	-1.00	-1.07	-0.58	-0.38	-1.86
Purchase of Investments	-41	-34	-7.82	-56	-26	-41	-19	-18	-38	-25	-13
Sale and/or Maturity of Investments	48	46	19	51	42	39	24	34	23	18	16
Net Cash From Financing Activities	1.63	1.19	2.76	2.73	3.86	3.58	5.09	0.84	2.84	1.17	2.64
Net Cash From Continuing Financing Activities	1.63	1.19	2.76	2.73	3.86	3.58	5.09	0.84	2.84	1.17	2.64
Issuance of Common Equity	0.96	-	0.85	-	1.15	-	1.80	-	1.72	-	1.42
Other Financing Activities, net	0.67	1.19	1.92	2.73	2.70	3.58	3.29	0.84	1.12	1.17	1.22
Effect of Exchange Rate Changes	-0.02	0.46	-0.10	-0.15	-0.29	-0.02	-0.26	0.06	-0.12	-0.29	0.27
Cash Interest Paid	0.03	0.03	0.03	0.02	-	-	0.00	0.01	0.02	0.02	0.02
Cash Income Taxes Paid	0.26	0.16	0.29	0.12	0.84	1.22	0.59	0.55	0.29	0.34	-0.43

This table presents Couchbase's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025
Total Assets	117	277	253	248	261
Total Current Assets	104	263	229	224	228
Cash & Equivalents	37	96	40	41	31
Short-Term Investments	20	110	128	112	117
Accounts Receivable	36	37	40	45	49
Prepaid Expenses	2.45	8.56	8.23	10	15
Other Current Assets	8.35	12	13	15	17
Plant, Property, & Equipment, net	6.51	4.29	7.43	5.33	7.21
Total Noncurrent Assets	7.14	9.46	16	18	25
Other Noncurrent Operating Assets	7.14	9.46	16	18	25
Total Liabilities & Shareholders' Equity	117	277	253	248	261
Total Liabilities	104	94	103	117	133
Total Current Liabilities	73	90	95	113	127
Accounts Payable	2.43	1.92	1.41	4.87	2.19
Accrued Expenses	4.15	3.23	6.08	4.58	8.44
Current Deferred Revenue	57	69	72	82	94
Current Employee Benefit Liabilities	9.11	16	13	18	21
Other Current Liabilities	-	0.00	3.12	3.21	1.36
Total Noncurrent Liabilities	31	3.22	7.82	4.83	5.65
Noncurrent Deferred Revenue	4.54	2.71	3.28	2.75	2.69
Other Noncurrent Operating Liabilities	1.36	0.51	4.54	2.08	2.96
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-246	183	150	130	128
Total Preferred & Common Equity	-246	183	150	130	128
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-246	183	150	130	128
Common Stock	37	525	562	621	693
Retained Earnings	-284	-342	-410	-491	-565
Accumulated Other Comprehensive Income / (Loss)	0.00	-0.20	-0.81	0.06	0.12

This table presents Couchbase's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	10/31/2021	4/30/2022	7/31/2022	10/31/2022	4/30/2023	7/31/2023	10/31/2023	4/30/2024	7/31/2024	10/31/2024	4/30/2025
Total Assets	260	267	265	242	249	244	232	243	236	222	247
Total Current Assets	248	245	242	220	226	219	207	218	211	194	214
Cash & Equivalents	141	48	46	39	46	41	47	52	63	33	28
Short-Term Investments	66	153	146	138	117	124	110	108	94	109	114
Accounts Receivable	23	25	29	23	42	32	30	35	31	29	44
Prepaid Expenses	8.19	8.01	9.66	7.77	6.84	8.03	7.45	10	10	11	12
Other Current Assets	9.22	12	12	12	13	13	13	13	13	13	17
Plant, Property, & Equipment, net	4.98	4.34	5.64	6.73	8.03	8.58	9.63	6.11	7.05	7.00	10
Total Noncurrent Assets	7.14	17	17	16	16	16	15	18	18	21	22
Other Noncurrent Operating Assets	7.14	17	17	16	16	16	15	18	18	21	22
Total Liabilities & Shareholders' Equity	260	267	265	242	249	244	232	243	236	222	247
Total Liabilities	68	93	98	84	109	108	97	114	109	96	121
Total Current Liabilities	64	85	90	77	102	102	90	110	107	91	115
Accounts Payable	3.52	2.64	5.58	3.52	6.87	3.16	3.17	4.07	5.03	4.72	4.57
Accrued Expenses	2.53	2.95	4.10	3.31	4.81	4.87	3.40	3.81	3.37	3.98	7.31
Current Deferred Revenue	48	68	67	58	79	80	72	90	82	68	92
Current Employee Benefit Liabilities	-	8.03	11	9.05	8.50	11	9.12	8.94	14	12	9.76
Other Current Liabilities	-	2.72	3.08	3.04	3.06	2.98	2.98	3.11	2.67	2.15	0.80
Total Noncurrent Liabilities	4.02	7.92	7.96	7.24	6.75	6.49	6.52	3.96	2.20	4.51	6.19
Noncurrent Deferred Revenue	2.73	2.29	2.47	2.58	2.87	3.22	3.78	2.57	1.03	0.83	3.25
Other Noncurrent Operating Liabilities	1.30	5.63	5.49	4.66	3.87	3.27	2.74	1.39	1.17	3.68	2.94
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	191	174	166	158	141	136	135	129	127	127	126
Total Preferred & Common Equity	191	174	166	158	141	136	135	129	127	127	126
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	191	174	166	158	141	136	135	129	127	127	126
Common Stock	520	537	545	553	574	589	605	641	658	676	709
Retained Earnings	-329	-362	-377	-394	-432	-453	-469	-512	-532	-550	-583
Accumulated Other Comprehensive Income / (Loss)	-0.03	-0.88	-1.04	-1.38	-0.49	-0.30	-0.11	-0.22	0.03	0.12	0.20

This table displays calculated financial ratios and metrics derived from Couchbase's official financial filings.

Metric	2020	2021	2022	2023	2024	2025
Period end date	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	25.16%	19.61%	25.32%	16.28%	16.35%
EBITDA Growth	0.00%	-24.55%	-111.84%	-19.42%	-28.87%	9.61%
EBIT Growth	0.00%	-34.13%	-76.92%	-19.09%	-16.97%	7.61%
NOPAT Growth	0.00%	-9.02%	-70.07%	-23.21%	-21.96%	6.96%
Net Income Growth	0.00%	-36.66%	-45.63%	-17.63%	-17.07%	6.90%
EPS Growth	0.00%	-44.65%	69.26%	35.44%	-11.11%	14.71%
Operating Cash Flow Growth	0.00%	-80.07%	-6.12%	0.94%	34.70%	41.14%
Free Cash Flow Firm Growth	0.00%	0.00%	-639.43%	-51.82%	-1.47%	-8.72%
Invested Capital Growth	0.00%	0.00%	-23.48%	20.67%	-28.68%	15.75%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	4.42%	4.93%	2.36%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	-7.82%	-14.97%	6.10%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	-5.71%	-5.72%	7.38%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	-9.19%	-5.09%	7.91%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	-5.19%	-6.35%	7.20%
EPS Q/Q Growth	0.00%	0.00%	0.00%	-233.04%	-4.29%	9.38%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	8.61%	-22.45%	12.25%	40.58%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.19%	11.02%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	5.81%	-8.68%	-28.98%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	90.55%	88.75%	88.04%	86.91%	87.73%	88.08%
EBITDA Margin	-18.33%	-18.24%	-32.31%	-30.79%	-34.12%	-26.51%
Operating Margin	-36.77%	-32.03%	-45.54%	-44.77%	-46.96%	-37.55%
EBIT Margin	-28.88%	-30.95%	-45.78%	-43.50%	-43.76%	-34.75%
Profit (Net Income) Margin	-35.45%	-38.71%	-47.13%	-44.24%	-44.54%	-35.64%
Tax Burden Percent	102.69%	102.68%	101.77%	101.54%	101.72%	102.47%
Interest Burden Percent	119.54%	121.80%	101.16%	100.15%	100.05%	100.08%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	0.00%	-296.61%	-59.21%	-41.08%	-57.13%	-57.86%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	0.00%	-27.28%	-28.71%	-25.43%	-31.46%	-28.64%
Return on Assets (ROA)	0.00%	-34.12%	-29.56%	-25.86%	-32.02%	-29.37%
Return on Common Equity (ROCE)	0.00%	5,420.43%	19.00%	-41.08%	-57.13%	-57.86%
Return on Equity Simple (ROE_SIMPLE)	0.00%	16.23%	-31.78%	-45.58%	-61.48%	-58.50%
Net Operating Profit after Tax (NOPAT)	-21	-23	-39	-49	-59	-55
NOPAT Margin	-25.74%	-22.42%	-31.88%	-31.34%	-32.87%	-26.29%
Net Nonoperating Expense Percent (NNEP)	0.00%	-105.52%	-15.85%	-10.67%	-13.05%	-13.03%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-32.29%	-45.37%	-43.14%
Cost of Revenue to Revenue	9.45%	11.25%	11.96%	13.09%	12.27%	11.92%
SG&A Expenses to Revenue	18.86%	15.01%	19.43%	21.57%	23.70%	24.18%
R&D to Revenue	38.38%	37.76%	41.80%	37.31%	35.59%	33.69%
Operating Expenses to Revenue	127.32%	120.78%	133.57%	131.69%	134.69%	125.63%
Earnings before Interest and Taxes (EBIT)	-24	-32	-57	-67	-79	-73
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-15	-19	-40	-48	-61	-56
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	5.58	4.45	9.21	7.28
Price to Tangible Book Value (P/TBV)	0.00	0.00	5.58	4.45	9.21	7.28
Price to Revenue (P/Rev)	2.04	1.63	8.27	4.32	6.68	4.43
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	3.83	6.60	3.23	5.82	3.73
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	1.85	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	1.85	0.00	0.00	0.00	0.00
Financial Leverage	0.00	-2.37	-1.21	-1.12	-1.15	-1.17
Leverage Ratio	0.00	8.69	2.00	1.59	1.78	1.97
Compound Leverage Factor	0.00	10.59	2.03	1.59	1.79	1.97
Debt to Total Capital	0.00%	64.92%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	64.92%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	676.13%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	-641.05%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	-1.32	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	1.69	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	-1.32	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	-1.08	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	1.38	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	-1.08	0.00	0.00	0.00	0.00
Altman Z-Score	0.00	-2.12	5.34	2.00	3.59	1.50
Noncontrolling Interest Sharing Ratio	0.00%	1,927.46%	132.09%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.00	1.42	2.91	2.42	1.99	1.79
Quick Ratio	0.00	1.27	2.69	2.19	1.76	1.54
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-4.74	-35	-53	-54	-59
Operating Cash Flow to CapEx	-461.93%	-1,389.78%	-5,076.19%	-729.45%	-570.98%	-524.11%
Free Cash Flow to Firm to Interest Expense	0.00	-0.68	-53.44	-526.95	-1,255.88	-978.58
Operating Cash Flow to Interest Expense	-4.67	-5.62	-63.38	-407.77	-625.42	-263.80
Operating Cash Flow Less CapEx to Interest Expense	-5.68	-6.03	-64.62	-463.67	-734.95	-314.13
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	0.88	0.63	0.58	0.72	0.82
Accounts Receivable Turnover	0.00	2.88	3.40	4.05	4.25	4.45
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	15.88	22.89	26.43	28.23	33.41
Accounts Payable Turnover	0.00	4.78	6.79	12.17	7.04	7.08
Days Sales Outstanding (DSO)	0.00	126.86	107.24	90.23	85.85	81.98
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	76.29	53.72	30.00	51.84	51.56
Cash Conversion Cycle (CCC)	0.00	50.57	53.52	60.23	34.02	30.42
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	0.00	-18	-23	-18	-23	-20
Invested Capital Turnover	0.00	-11.22	-6.00	-7.59	-8.73	-9.80
Increase / (Decrease) in Invested Capital	0.00	-18	-4.32	4.70	-5.17	3.66
Enterprise Value (EV)	0.00	396	815	500	1,048	781
Market Capitalization	168	168	1,021	668	1,202	929
Book Value per Share	$0.00	($43.09)	$4.20	$3.33	$2.71	$2.44
Tangible Book Value per Share	$0.00	($43.09)	$4.20	$3.33	$2.71	$2.44
Total Capital	0.00	38	183	150	130	128
Total Debt	0.00	25	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	25	0.00	0.00	0.00	0.00
Net Debt	0.00	-32	-206	-168	-154	-147
Capital Expenditures (CapEx)	4.71	2.82	0.82	5.65	4.71	3.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-26	-33	-34	-42	-46
Debt-free Net Working Capital (DFNWC)	0.00	31	173	135	112	101
Net Working Capital (NWC)	0.00	31	173	135	112	101
Net Nonoperating Expense (NNE)	8.02	17	19	20	21	20
Net Nonoperating Obligations (NNO)	0.00	-32	-206	-168	-154	-147
Total Depreciation and Amortization (D&A)	8.70	13	17	20	17	17
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-25.33%	-26.93%	-21.82%	-23.25%	-22.01%
Debt-free Net Working Capital to Revenue	0.00%	29.71%	139.78%	86.89%	62.09%	48.25%
Net Working Capital to Revenue	0.00%	29.71%	139.78%	86.89%	62.09%	48.25%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($2.37)	($1.53)	($1.70)	($1.45)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	25.78M	44.79M	47.18M	51.31M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($2.37)	($1.53)	($1.70)	($1.45)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	25.78M	44.79M	47.18M	51.31M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	44.17M	45.61M	49.26M	53.10M
Normalized Net Operating Profit after Tax (NOPAT)	-21	-23	-39	-47	-56	-55
Normalized NOPAT Margin	-25.74%	-22.42%	-31.88%	-30.59%	-30.85%	-26.29%
Pre Tax Income Margin	-34.53%	-37.70%	-46.31%	-43.57%	-43.78%	-34.78%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	-5.12	-4.59	-86.22	-666.88	-1,832.21	-1,213.18
NOPAT to Interest Expense	-4.56	-3.32	-60.03	-480.40	-1,376.18	-917.64
EBIT Less CapEx to Interest Expense	-6.13	-4.99	-87.46	-722.78	-1,941.74	-1,263.52
NOPAT Less CapEx to Interest Expense	-5.57	-3.73	-61.28	-536.30	-1,485.72	-967.98
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	-8.47%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Couchbase's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	10/31/2022	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	25.09%	18.71%	17.63%	8.41%	18.82%	20.34%	25.20%	19.59%	12.69%	9.65%	10.12%
EBITDA Growth	0.02%	-41.79%	-5.91%	-54.07%	-0.42%	-64.07%	-5.38%	2.68%	-8.52%	37.94%	35.98%
EBIT Growth	-4.72%	-28.16%	-7.96%	-37.68%	0.19%	-25.74%	0.43%	6.34%	-7.39%	27.83%	20.07%
NOPAT Growth	-7.11%	-46.05%	-18.67%	-43.56%	-5.73%	-22.11%	-0.03%	3.75%	-9.65%	29.92%	16.40%
Net Income Growth	-4.73%	-25.52%	-10.29%	-34.37%	2.53%	-28.82%	4.02%	3.66%	-11.67%	27.06%	15.79%
EPS Growth	0.00%	-116.02%	-6.67%	-29.41%	8.11%	-18.92%	12.50%	11.36%	-2.94%	34.09%	21.43%
Operating Cash Flow Growth	25.46%	-284.73%	16.57%	93.22%	13.43%	36.78%	121.71%	-834.49%	-32.58%	167.57%	-535.09%
Free Cash Flow Firm Growth	128.15%	0.00%	-247.18%	3.18%	-877.43%	39.71%	63.08%	-43.90%	-95.19%	-38.50%	-290.41%
Invested Capital Growth	-206.86%	20.67%	15.32%	-17.64%	-11.52%	-28.68%	-37.19%	2.53%	29.01%	15.75%	49.65%
Revenue Q/Q Growth	-3.10%	7.95%	-1.51%	5.23%	6.20%	9.33%	2.47%	0.51%	0.08%	6.38%	2.92%
EBITDA Q/Q Growth	-14.77%	-3.84%	-39.29%	3.21%	25.20%	-69.67%	-6.19%	10.62%	16.59%	2.98%	6.67%
EBIT Q/Q Growth	-8.70%	-1.78%	-27.38%	2.30%	21.20%	-28.21%	-0.87%	8.10%	9.65%	13.83%	-11.72%
NOPAT Q/Q Growth	-8.92%	-11.51%	-21.79%	2.95%	19.79%	-28.79%	0.23%	6.62%	8.62%	17.68%	-19.01%
Net Income Q/Q Growth	-8.51%	0.38%	-31.67%	5.60%	21.29%	-31.66%	1.90%	5.24%	8.76%	14.00%	-13.25%
EPS Q/Q Growth	-8.82%	0.00%	-29.73%	8.33%	22.73%	-29.41%	4.55%	7.14%	10.26%	17.14%	-13.79%
Operating Cash Flow Q/Q Growth	-92.29%	30.69%	29.62%	92.77%	-2,355.30%	49.38%	124.17%	-411.10%	-248.35%	125.79%	-255.64%
Free Cash Flow Firm Q/Q Growth	111.65%	-1,462.49%	-12.60%	45.81%	6.49%	-5.66%	31.05%	-111.22%	-26.85%	25.03%	-94.37%
Invested Capital Q/Q Growth	25.54%	5.81%	-25.81%	-33.33%	29.41%	-8.68%	-34.13%	5.28%	48.59%	-28.98%	19.84%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	87.36%	85.70%	85.55%	86.30%	88.84%	89.74%	88.93%	87.47%	87.30%	88.61%	87.87%
EBITDA Margin	-29.30%	-28.19%	-38.22%	-35.16%	-24.76%	-38.43%	-32.17%	-28.61%	-23.85%	-21.75%	-19.72%
Operating Margin	-43.03%	-44.45%	-54.96%	-50.69%	-38.29%	-45.11%	-43.91%	-40.80%	-37.26%	-28.83%	-33.34%
EBIT Margin	-42.21%	-39.80%	-51.47%	-47.79%	-35.46%	-41.58%	-40.93%	-37.42%	-33.79%	-27.37%	-29.71%
Profit (Net Income) Margin	-43.25%	-39.92%	-53.36%	-47.87%	-35.48%	-42.73%	-40.90%	-38.56%	-35.16%	-28.42%	-31.28%
Tax Burden Percent	102.31%	100.15%	103.55%	100.09%	100.07%	102.76%	99.93%	102.89%	103.96%	103.76%	105.18%
Interest Burden Percent	100.16%	100.15%	100.12%	100.09%	100.00%	100.00%	100.00%	100.15%	100.10%	100.09%	100.09%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-37.26%	-41.08%	-44.75%	-50.22%	-51.40%	-57.13%	-58.74%	-59.92%	-61.40%	-57.86%	-55.90%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-24.93%	-23.26%	-32.08%	-30.89%	-25.65%	-29.90%	-31.67%	-31.03%	-30.43%	-22.55%	-26.06%
Return on Assets (ROA)	-25.55%	-23.33%	-33.26%	-30.94%	-25.67%	-30.72%	-31.65%	-31.97%	-31.66%	-23.42%	-27.43%
Return on Common Equity (ROCE)	-37.26%	-41.08%	-44.75%	-50.22%	-51.40%	-57.13%	-58.74%	-59.92%	-61.40%	-57.86%	-55.90%
Return on Equity Simple (ROE_SIMPLE)	-41.19%	0.00%	-50.04%	-55.94%	-55.74%	0.00%	-61.45%	-62.02%	-63.45%	0.00%	-56.55%
Net Operating Profit after Tax (NOPAT)	-12	-13	-16	-15	-12	-16	-16	-15	-13	-11	-13
NOPAT Margin	-30.12%	-31.12%	-38.47%	-35.49%	-26.80%	-31.57%	-30.74%	-28.56%	-26.08%	-20.18%	-23.34%
Net Nonoperating Expense Percent (NNEP)	-2.70%	-1.96%	-3.35%	-2.99%	-2.38%	-3.47%	-3.22%	-3.21%	-3.14%	-3.01%	-2.97%
Return On Investment Capital (ROIC_SIMPLE)	-	-8.62%	-	-	-	-12.13%	-	-	-	-8.68%	-10.46%
Cost of Revenue to Revenue	12.64%	14.30%	14.45%	13.70%	11.16%	10.26%	11.07%	12.53%	12.70%	11.39%	12.13%
SG&A Expenses to Revenue	22.90%	19.72%	23.48%	24.24%	23.44%	23.64%	24.52%	24.49%	24.45%	23.32%	19.75%
R&D to Revenue	36.30%	36.04%	37.52%	37.77%	34.71%	32.92%	34.77%	33.67%	33.87%	32.54%	33.95%
Operating Expenses to Revenue	130.39%	130.15%	140.52%	137.00%	127.13%	134.84%	132.84%	128.27%	124.56%	117.43%	121.21%
Earnings before Interest and Taxes (EBIT)	-16	-17	-21	-21	-16	-21	-21	-19	-17	-15	-17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-11	-12	-16	-15	-11	-19	-17	-15	-12	-12	-11
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.63	4.45	4.97	5.71	5.42	9.21	9.21	7.62	6.51	7.28	7.43
Price to Tangible Book Value (P/TBV)	3.63	4.45	4.97	5.71	5.42	9.21	9.21	7.62	6.51	7.28	7.43
Price to Revenue (P/Rev)	3.87	4.32	4.35	4.71	4.27	6.68	6.25	4.86	4.03	4.43	4.36
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	2.67	3.23	3.34	3.70	3.36	5.82	5.41	4.07	3.34	3.73	3.70
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-1.07	-1.12	-1.16	-1.19	-1.14	-1.15	-1.20	-1.23	-1.14	-1.17	-1.18
Leverage Ratio	1.44	1.59	1.64	1.68	1.62	1.78	1.82	1.83	1.73	1.97	1.92
Compound Leverage Factor	1.44	1.59	1.64	1.69	1.62	1.78	1.82	1.83	1.74	1.97	1.92
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	2.91	2.66	2.41	2.67	2.83	4.36	4.37	3.25	2.93	2.23	2.48
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.85	2.42	2.22	2.16	2.30	1.99	1.99	1.97	2.13	1.79	1.87
Quick Ratio	2.60	2.19	2.02	1.95	2.07	1.76	1.78	1.75	1.87	1.54	1.62
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1.30	-18	-20	-11	-10	-11	-7.34	-15	-20	-15	-29
Operating Cash Flow to CapEx	-910.33%	-656.99%	-557.53%	-48.46%	-1,195.40%	-501.95%	156.68%	-454.55%	-2,897.94%	1,162.13%	-364.68%
Free Cash Flow to Firm to Interest Expense	49.83	-706.10	-795.08	-598.41	0.00	0.00	0.00	-534.47	-1,156.52	-1,052.79	-1,909.87
Operating Cash Flow to Interest Expense	-566.15	-408.12	-287.24	-28.83	0.00	0.00	0.00	-167.24	-993.82	311.29	-452.20
Operating Cash Flow Less CapEx to Interest Expense	-628.35	-470.24	-338.76	-88.33	0.00	0.00	0.00	-204.03	-1,028.12	284.50	-576.20
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.59	0.58	0.62	0.65	0.72	0.72	0.77	0.83	0.90	0.82	0.88
Accounts Receivable Turnover	6.58	4.05	4.82	5.35	6.47	4.25	4.96	6.24	6.94	4.45	5.48
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	25.31	26.43	26.02	23.11	20.97	28.23	26.92	25.43	24.61	33.41	26.37
Accounts Payable Turnover	5.24	12.17	4.53	5.19	6.84	7.04	3.99	5.47	6.04	7.08	6.05
Days Sales Outstanding (DSO)	55.46	90.23	75.77	68.27	56.40	85.85	73.62	58.49	52.63	81.98	66.62
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	69.70	30.00	80.57	70.36	53.37	51.84	91.38	66.71	60.44	51.56	60.31
Cash Conversion Cycle (CCC)	-14.25	60.23	-4.80	-2.08	3.03	34.02	-17.76	-8.23	-7.82	30.42	6.31
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	-19	-18	-23	-30	-21	-23	-31	-29	-15	-20	-16
Invested Capital Turnover	-11.68	-7.59	-6.51	-5.87	-8.47	-8.73	-7.07	-6.66	-11.21	-9.80	-9.17
Increase / (Decrease) in Invested Capital	-13	4.70	4.10	-4.54	-2.21	-5.17	-8.44	0.77	6.20	3.66	15
Enterprise Value (EV)	396	500	537	609	576	1,048	1,029	809	683	781	795
Market Capitalization	573	668	701	775	732	1,202	1,189	965	825	929	937
Book Value per Share	$3.53	$3.33	$3.09	$2.92	$2.87	$2.71	$2.62	$2.52	$2.47	$2.44	$2.38
Tangible Book Value per Share	$3.53	$3.33	$3.09	$2.92	$2.87	$2.71	$2.62	$2.52	$2.47	$2.44	$2.38
Total Capital	158	150	141	136	135	130	129	127	127	128	126
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-177	-168	-164	-166	-157	-154	-160	-156	-142	-147	-142
Capital Expenditures (CapEx)	1.62	1.55	1.29	1.07	1.07	1.29	1.00	1.07	0.58	0.38	1.86
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-35	-34	-40	-48	-39	-42	-51	-53	-39	-46	-42
Debt-free Net Working Capital (DFNWC)	143	135	124	117	117	112	109	104	103	101	100
Net Working Capital (NWC)	143	135	124	117	117	112	109	104	103	101	100
Net Nonoperating Expense (NNE)	5.06	3.66	6.10	5.34	3.98	5.59	5.22	5.16	4.69	4.53	4.49
Net Nonoperating Obligations (NNO)	-177	-168	-164	-166	-157	-154	-160	-156	-142	-147	-142
Total Depreciation and Amortization (D&A)	4.98	4.83	5.43	5.45	4.90	1.58	4.50	4.55	5.13	3.09	5.65
Debt-free, Cash-free Net Working Capital to Revenue	-23.27%	-21.82%	-24.79%	-29.42%	-22.96%	-23.25%	-27.02%	-26.44%	-18.97%	-22.01%	-19.63%
Debt-free Net Working Capital to Revenue	96.28%	86.89%	76.87%	71.48%	68.33%	62.09%	57.13%	52.09%	50.40%	48.25%	46.44%
Net Working Capital to Revenue	96.28%	86.89%	76.87%	71.48%	68.33%	62.09%	57.13%	52.09%	50.40%	48.25%	46.44%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.37)	($0.37)	($0.48)	($0.44)	($0.34)	($0.44)	($0.42)	($0.39)	($0.35)	($0.29)	($0.33)
Adjusted Weighted Average Basic Shares Outstanding	44.93M	44.79M	45.84M	46.71M	47.59M	47.18M	49.79M	50.82M	51.83M	51.31M	53.65M
Adjusted Diluted Earnings per Share	($0.37)	($0.37)	($0.48)	($0.44)	($0.34)	($0.44)	($0.42)	($0.39)	($0.35)	($0.29)	($0.33)
Adjusted Weighted Average Diluted Shares Outstanding	44.93M	44.79M	45.84M	46.71M	47.59M	47.18M	49.79M	50.82M	51.83M	51.31M	53.65M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	45.17M	45.61M	46.41M	47.07M	48.07M	49.26M	50.31M	51.32M	52.35M	53.10M	54.08M
Normalized Net Operating Profit after Tax (NOPAT)	-12	-12	-16	-15	-12	-16	-16	-15	-13	-11	-13
Normalized NOPAT Margin	-30.12%	-28.32%	-38.40%	-35.49%	-26.80%	-31.57%	-30.74%	-28.56%	-26.08%	-20.18%	-23.34%
Pre Tax Income Margin	-42.28%	-39.86%	-51.53%	-47.83%	-35.46%	-41.58%	-40.93%	-37.48%	-33.82%	-27.39%	-29.74%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-625.96	-662.56	-844.00	-1,145.22	0.00	0.00	0.00	-665.76	-1,026.12	-1,073.64	-1,119.53
NOPAT to Interest Expense	-446.71	-518.06	-630.92	-850.46	0.00	0.00	0.00	-508.06	-791.99	-791.65	-879.34
EBIT Less CapEx to Interest Expense	-688.15	-724.68	-895.52	-1,204.72	0.00	0.00	0.00	-702.55	-1,060.41	-1,100.43	-1,243.53
NOPAT Less CapEx to Interest Expense	-508.90	-580.18	-682.44	-909.96	0.00	0.00	0.00	-544.85	-826.28	-818.44	-1,003.34
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Key Financial Trends

Couchbase reported a solid revenue ramp in Q1 2026, driven by strong demand for its database platform, but profitability remains challenged. Below are the key takeaways from the last four years of quarterly results and financial position:

Revenue grew 10.1% year-over-year in Q1 2026, extending a multi-quarter top-line acceleration.
Gross margins have stayed near 88%, reflecting the high-value nature of Couchbase’s software offerings.
The balance sheet remains debt-free with net cash of $142 M (cash & short-term investments), providing runway for investment.
Current ratio of 1.87x and quick ratio of 1.62x indicate adequate liquidity despite ongoing cash burn.
Altman Z-Score of 2.48 keeps Couchbase in the safe zone for financial distress, though below peer-average levels.
Heavy R&D (34% of revenue) and SG&A (20% of revenue) spending underscores growth-stage investment, delaying breakeven.
Q1 2026 net loss of $17.7 M, while narrower than prior quarters, remains significant and underscores ongoing unprofitability.
Free cash flow to the firm was negative $28.6 M in Q1, highlighting continued operating cash outflows.
Operating margin of –33.3% in Q1 2026 shows costs are still outpacing revenue gains, even as losses moderate.

In summary, Couchbase continues to deliver accelerating revenue growth and strong gross margins, but high operating expenses and cash burn keep the company unprofitable. Its debt-free balance sheet offers flexibility, but investors will want to see further progress on operating leverage and positive free cash flow in the quarters ahead.

06/21/25 05:15 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Couchbase's Financials

When does Couchbase's fiscal year end?

According to the most recent income statement we have on file, Couchbase's financial year ends in January. Their financial year 2025 ended on January 31, 2025.

How has Couchbase's net income changed over the last 5 years?

Couchbase's net income appears to be on an upward trend, with a most recent value of -$74.65 million in 2025, rising from -$29.26 million in 2020. The previous period was -$80.18 million in 2024. Find out what analysts predict for Couchbase in the coming months.

What is Couchbase's operating income?

Couchbase's total operating income in 2025 was -$78.66 million, based on the following breakdown:

Total Gross Profit: $184.51 million
Total Operating Expenses: $263.16 million

How has Couchbase's revenue changed over the last 5 years?

Over the last 5 years, Couchbase's total revenue changed from $82.52 million in 2020 to $209.47 million in 2025, a change of 153.8%.

How much debt does Couchbase have?

Couchbase's total liabilities were at $132.98 million at the end of 2025, a 13.3% increase from 2024, and a 28.2% increase since 2021.

How much cash does Couchbase have?

In the past 4 years, Couchbase's cash and equivalents has ranged from $30.54 million in 2025 to $95.69 million in 2022, and is currently $30.54 million as of their latest financial filing in 2025.

How has Couchbase's book value per share changed over the last 5 years?

Over the last 5 years, Couchbase's book value per share changed from 0.00 in 2020 to 2.44 in 2025, a change of 243.8%.

Related Companies

This page (NASDAQ:BASE) was last updated on 6/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Couchbase (BASE) Financials

Key Financial Trends

Frequently Asked Questions About Couchbase's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Couchbase (BASE) Financials

Annual Income Statements for Couchbase

Quarterly Income Statements for Couchbase

Annual Cash Flow Statements for Couchbase

Quarterly Cash Flow Statements for Couchbase

Annual Balance Sheets for Couchbase

Quarterly Balance Sheets for Couchbase

Annual Metrics And Ratios for Couchbase

Quarterly Metrics And Ratios for Couchbase

Key Financial Trends

Frequently Asked Questions About Couchbase's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools